LEADER 01067nam0-2200325 --450 001 9910549196903321 005 20220321112121.0 010 $a978-88-6760-522-4 020 $aIT$b2018-14559 100 $a20220321d2018----kmuy0itay5050 ba 101 0 $aita 102 $aIT 105 $aa 001yy 200 1 $a<>tirocinio on line$esperimentare in presenza, riflettere e coooperare a distanza$fEttore Felisatti, Pietro Tonegato, Mariacristina Calogero 210 $aLecce$aRovato$cPensa multimedia$d2018 215 $a213 p.$cill.$d24 cm 225 1 $aOpen learning$v16 320 $aContiene riferimenti bibl. (pp. 165-179) 610 0 $aTirocinio$aImpiego [di] Internet 676 $a331.25922$v23$zita 700 1$aFelisatti,$bEttore$0600163 701 1$aCalogero,$bMariacristina$01210509 701 1$aTonegato,$bPietro$01210510 801 0$aIT$bUNINA$gREICAT$2UNIMARC 901 $aBK 912 $a9910549196903321 952 $aCOLLEZ. 2972 (16)$b316/2022$fFSPBC 959 $aFSPBC 996 $aTirocinio on line$92793632 997 $aUNINA LEADER 01803nam 2200421 450 001 9910583361803321 005 20230120002633.0 010 $a0-12-812440-7 010 $a0-12-812439-3 035 $a(CKB)3710000001442213 035 $a(MiAaPQ)EBC4901161 035 $a(EXLCZ)993710000001442213 100 $a20170727h20172017 uy 0 101 0 $aeng 135 $aurcnu|||||||| 181 $2rdacontent 182 $2rdamedia 183 $2rdacarrier 200 10$aTreating life-threatening bleedings $edevelopment of recombinant coagulation factor VIIa /$fUlla Hedner 210 1$aLondon, England :$cAcademic Press,$d2017. 215 $a1 online resource (215 pages) 320 $aIncludes bibliographical references at the end of each chapters and index. 327 $aClassical bleeding disease -- My encounter with hemophilia -- The first years at novo nordisk -- The development of recombinant FVIIa -- The futher use and development of rFVIIa -- Legal issues regarding the use of rFVIIa in hemophilia patients with inhibitors -- Treatment with rFVIIa in Malmo? --Mechanism of action and dosage -- The continued development of rFVIIa during the 2000s -- Three different descriptions of how rFVIIa was developed -- Some final remarks. 606 $aBlood coagulation factors 606 $aBlood coagulation factor VIII 606 $aBlood coagulation disorders$xTreatment 615 0$aBlood coagulation factors. 615 0$aBlood coagulation factor VIII. 615 0$aBlood coagulation disorders$xTreatment. 676 $a612.115 700 $aHedner$b U$g(Ulla),$0855306 801 0$bMiAaPQ 801 1$bMiAaPQ 801 2$bMiAaPQ 906 $aBOOK 912 $a9910583361803321 996 $aTreating life-threatening bleedings$91909491 997 $aUNINA